Table 2. Changes in food intake during in vivo study

Groups	Week 1	Week 2	Week 3	Week 4	Week 5	Week 6	Week 7	Week 8	Week 9	Week 10	Week 11	Week 12
Control (G1)¹⁾	28.93±2.04⁵⁾	29.39±1.32^NS3)	29.39±1.07^NS	28.93±0.95^NS	29.76±1.54^2),NS	30.14±0.62^NS	29.70±1.35^NS	30.36±1.93^NS	30.07±0.41^NS	29.87±1.29^NS	28.50±4.15^NS	29.63±1.55^NS
HFD (G2)	18.66±2.20	18.54±1.96	20.46±2.16	21.73±0.65	20.20±3.77	20.72±2.41	20.27±2.13	17.03±2.05	21.34±0.41	19.50±2.10	17.46±1.53	19.09±1.64
Orlistat (10 mg/kg, G3)	19.34±1.46^NS4)	16.40±2.31^NS	20.54±1.52^NS	21.63±0.66^NS	18.60±1.23^NS	20.97±2.20^NS	19.70±1.61^NS	16.61±0.81^NS	20.91±0.65^NS	17.43±2.75^NS	19.66±1.29^NS	18.50±1.86^NS
Policosanol (5 mg/kg, G4)	18.26±1.04^NS	15.98±2.27^NS	19.20±3.81^NS	20.87±0.63^NS	17.70±2.05^NS	19.70±2.17^NS	19.61±2.26^NS	16.84±2.71^NS	22.26±0.75^NS	19.21±2.06^NS	19.56±1.88^NS	17.63±1.63^NS
Policosanol (10 mg/kg, G5)	17.80±2.35^NS	16.47±2.59^NS	20.57±5.91^NS	20.97±0.83^NS	17.33±1.01^NS	19.44±3.25^NS	19.63±1.43^NS	16.94±1.13^NS	22.17±0.57^NS	17.97±3.04^NS	19.14±1.26^NS	18.41±1.54^NS
Policosanol (20 mg/kg, G6)	17.21±2.37^NS	17.26±2.84^NS	19.00±2.71^NS	20.66±2.31^NS	17.37±2.03^NS	18.73±3.03^NS	20.04±1.96^NS	15.89±1.81^NS	21.37±0.73^NS	16.27±2.37^NS	17.36±1.37^NS	18.00±0.95^NS

Group 1 (G1), normal control group; Group 2 (G2), HFD-induced group; Group 3 (G3), treated orlistat drug (10 mg/kg) in HFD-induced group; Group 4 (G4), treated policosanol (5 mg/kg) in HFD-induced group; Group 5 (G5), treated policosanol (10 mg/kg) in HFD-induced group; Group 6 (G6), treated policosanol (20 mg/kg) in HFD-induced group.
Gray color means treatment of policosanol and orlistat period time in mice model.
Normal control group (G1) showed no significant variation in food intake throughout the 12-week experimental period as compared to Week 1; NS, not significant (p>0.05).
The treated groups (G3-G6) showed no significant variation in food intake as compared to the HFD control group (G2); NS, not significant (p>0.05).
All values mean±SD (n=8).